[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369244-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369244-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","polygenic-risk-scores-for-pan-cancer-risk-prediction-in-the-chinese-population-a-population-based-cohort-study-based-on-the-china-kadoorie-biobank","Polygenic risk scores for pan-cancer risk prediction in the Chinese population - A population-based cohort study based on the China Kadoorie Biobank","","Polygenic risk scores (PRSs) are widely used to predict cancer risk in European populations, but their usefulness in Chinese people has remained unclear. This study built 80 PRSs for 13 common cancers using seven methods and evaluated them in 100,219 participants from the China Kadoorie Biobank. Optimal PRSs defined genetic risk, then site-specific and cross-cancer associations were assessed. Ten-year absolute risk trajectories across PRS strata and modifiable risk scores were modeled, and the explained relative risk of PRSs with modifiable risk factors was quantified.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/polygenic-risk-scores-for-pan-cancer-risk-prediction-in-the-chinese-population-a-population-based-cohort-study-based-on-the-china-kadoorie-biobank/369244/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/polygenic-risk-scores-for-pan-cancer-risk-prediction-in-the-chinese-population-a-population-based-cohort-study-based-on-the-china-kadoorie-biobank/369244.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address about polygenic risk scores?","Question",{"text":63,"@type":64},"The study evaluates whether polygenic risk scores developed for cancer risk prediction in European populations perform effectively in the Chinese population.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the PRS model development and evaluation conducted?",{"text":68,"@type":64},"Researchers constructed 80 PRSs for 13 common cancers using seven schemes and tested them in 100,219 participants from the China Kadoorie Biobank.",{"name":70,"@type":61,"acceptedAnswer":71},"What metrics and analyses were used to quantify risk?",{"text":72,"@type":64},"The study used optimal PRSs to define genetic risk, assessed site-specific and cross-cancer associations, modeled 10-year absolute risk trajectories across risk strata, and quantified explained relative risk.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369244,1790495494,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","OPEN ACCESS  \nCitation: Zhu M, Zhu X, Han Y, Ma Z, Ji C, Wang T, et al. (2025) Polygenic risk scores for pan-cancer risk prediction in the Chinese population: A population-based cohort study based on the China Kadoorie Biobank. PLoS Med 22(2): e1004534 . [https://doi.org/10.1371/](https://doi.org/10.1371/)[ ](https://doi.org/10.1371/)[journal.pmed.1004534](journal.pmed.1004534)  \nAcademic Editor: Steven C Moore, National Cancer Institute, UNITED STATES OF AMERICA Received: August 27, 2024  \nAccepted: January 13, 2025  \nPublished: February 28, 2025  \nCopyright: © 2025 Zhu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: CKB data are available to all bona fide researchers. Details of how to access and details of the data release schedule are available from [www.ckbiobank](www.ckbiobank). org/site/Data+Access. As stated in the access policy, the CKB study group must maintain the integrity of the database for future use and regulate data access to comply with prior conditions agreed with the Chinese government.  \nRESEARCH ARTICLE  \nPolygenic risk scores for pan-cancer risk prediction in the Chinese population:  \nA population-based cohort study based on the China Kadoorie Biobank  \nMeng Zhu1,2,3‡, Xia Zhu1‡, Yuting Han4‡, Zhimin Ma1, Chen Ji1, Tianpei Wang1, Caiwang Yan1,2,3, Ci Song1,2,3, Canqing Yu4,5,6, Dianjianyi Sun4,5,6, Yue Jiang1,2, Jiaping Chen1,2, Ling Yang7,8, Yiping Chen7,8, Huaidong Du7,8, Robin Walters7,8, IonaY Millwood7,8, Juncheng Dai1,2,9, Hongxia Ma1,2,9, Zhengdong Zhang2, Zhengming Chen8, Zhibin Hu1,2, Jun Lv4,5,6,10, Guangfu Jin1,2,3*, Liming Li4,5,6*, Hongbing Shen1,2*, on behalf of the China Kadoorie Biobank Collaborative Group¶  \n1 Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China, 2 Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine and China International Cooperation Center for Environment and Human Health, Nanjing Medical University, Nanjing, China, 3 Department of Chronic Non-Communicable Disease Control, The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi Center for Disease Control and Prevention, Wuxi Medical Center, Nanjing Medical University, Wuxi, China, 4 Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China, 5 Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China, 6 Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China, 7 Medical Research Council Population Health Research Unit atthe University of Oxford, Oxford, United Kingdom, 8 Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom,  \n9 Genomic Science and Precision Medicine Institute, Gusu School, Nanjing Medical University, Nanjing, China, 10 State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China  \n‡ These authors share co-first authorship on this work.  \n¶Members of the China Kadoorie Biobank Collaborative Group are provided in the Supporting information (S4 Text).  \n* [guangfujin@njmu.edu.cn](guangfujin@njmu.edu.cn) (GJ); [lmlee@bjmu.edu.cn](lmlee@bjmu.edu.cn) (LL); [hbshen@njmu.edu.cn](hbshen@njmu.edu.cn) (HS)  \nAbstract  \nBackground  \nPolygenic risk scores (PRSs) have been extensively developed for cancer risk prediction in European populations, but their effectiveness in the Chinese population remains uncertain.  \nMethods and findings  \nWe constructed 80 PRSs for the 13 most common cancers using seven schemes and evaluated these PRSs in 100,219 participants f","cbCaioSjfq9DFe1I","https://ap.wps.com/l/cbCaioSjfq9DFe1I","pdf",2479335,22,"English","# Abstract\n## Background\n## Methods and findings\n## Data availability and security\n## Funding and competing interests\n## Abbreviations","[{\"question\":\"What problem does the study address about polygenic risk scores?\",\"answer\":\"The study evaluates whether polygenic risk scores developed for cancer risk prediction in European populations perform effectively in the Chinese population.\"},{\"question\":\"How was the PRS model development and evaluation conducted?\",\"answer\":\"Researchers constructed 80 PRSs for 13 common cancers using seven schemes and tested them in 100,219 participants from the China Kadoorie Biobank.\"},{\"question\":\"What metrics and analyses were used to quantify risk?\",\"answer\":\"The study used optimal PRSs to define genetic risk, assessed site-specific and cross-cancer associations, modeled 10-year absolute risk trajectories across risk strata, and quantified explained relative risk.\"}]","Polygenic risk scores for pan-cancer risk prediction in the Chinese population - A population-based cohort study based on the China Kadoorie Biobank | PDF",1790181570,55,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d9927d4fd32161c809820beface964e.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c50c55b3a7efae93d1dcca4598b30fb.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/707d0c11419b10bb3c65739c52312897.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36a537a242ab4ae91f239be0e2d55b2f.webp",980,1268]